Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/25238
Title: Resolution of autoimmune oophoritis after thymectomy in a myasthenia gravis patient
Authors: Uludağ Üniversitesi/Tıp Fakültesi/Pediatrik Endokrinoloji Anabilim Dalı.
Uludağ Üniversitesi/Tıp Fakültesi/Pediatrik Nöroloji Anabilim Dalı.
0000-0002-1684-1053
0000-0003-0710-5422
Çakır, Esra Deniz Papatya
Özdemir, Özlem
Eren, Erdal
Saǧlam, Halil
Okan, Mehmet Sait
Tarım, Ömer Faruk
AAM-1734-2020
C-7392-2019
AAH-1155-2021
57217886648
26647804400
36113153400
35612700100
6701707256
54685136100
Keywords: Endocrinology & metabolism
Pediatrics
Autoimmune oophoritis
Myasthenia gravis
Thymectomy
Issue Date: Dec-2011
Publisher: Galenos Yayıncılık
Citation: Çakır, E. D. P. vd. (2011). "Resolution of autoimmune oophoritis after thymectomy in a myasthenia gravis patient". Journal of Clinical Research in Pediatric Endocrinology, 3(4), 212-215.
Abstract: Myasthenia gravis (MG) is an autoimmune disorder characterized by autoantibodies against acetylcholine receptors. MG is generally an isolated disorder but may occur concomitantly with other autoimmune diseases. We describe an eighteen-year-old girl with MG who was admitted to our clinic with secondary amenorrhea and diagnosed as autoimmune oophoritis. Since her myasthenic symptoms did not resolve with anticholinesterase therapy, thymectomy was performed. After thymectomy, her menses have been regular without any hormonal replacement therapy. To our knowledge, this is the first report on a patient with autoimmune ovarian insufficiency and MG in whom premature ovarian insufficiency resolved after thymectomy, without hormonal therapy.
URI: https://doi.org/10.4274/jcrpe.378
https://jag.journalagent.com/jcrpe/pdfs/JCRPE_3_4_212_215.pdf
http://hdl.handle.net/11452/25238
ISSN: 1308-5727
1308-5735
Appears in Collections:PubMed
Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Çakır_vd_2011.pdf66.13 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.